| BREA |
Brera Holdings PLC |
Class B Ordinary Shares, $0.005 nominal value per share |
14% |
$272,689,440 |
+$54,300,840 |
9,089,648 |
+25% |
ARK Investment Management LLC |
31 Dec 2025 |
| TWST |
Twist Bioscience Corp |
Common Stock |
12% |
$239,787,181 |
+$37,344,876 |
7,559,495 |
+18% |
ARK Investment Management LLC |
31 Dec 2025 |
| PACB |
Pacific Biosciences of California, Inc. |
Common Stock |
12% |
$69,684,106 |
+$11,856,034 |
37,264,228 |
+21% |
ARK Investment Management LLC |
31 Dec 2025 |
| BEAM |
Beam Therapeutics Inc. |
Common Stock |
12% |
$345,590,479 |
+$57,021,481 |
12,467,189 |
+20% |
ARK Investment Management LLC |
31 Dec 2025 |
| NTLA |
Intellia Therapeutics, Inc. |
Common Stock |
12% |
$127,723,843 |
+$20,570,433 |
14,207,324 |
+19% |
ARK Investment Management LLC |
31 Dec 2025 |
| CRSP |
CRISPR Therapeutics AG |
Common Stock |
11% |
$634,293,720 |
-$24,525,854 |
9,786,973 |
-3.7% |
ARK Investment Management LLC |
30 Sep 2025 |
| TXG |
10x Genomics, Inc. |
Class A Common Stock, $0.00001 par value per share |
10% |
$138,963,659 |
-$11,202,726 |
11,887,396 |
-7.5% |
ARK Investment Management LLC |
30 Sep 2025 |
| CERS |
CERUS CORP |
Common Stock |
10% |
$27,082,722 |
-$2,266,079 |
19,207,604 |
-7.7% |
ARK Investment Management LLC |
30 Jun 2025 |
| ARCT |
Arcturus Therapeutics Holdings Inc. |
Common Stock |
9.2% |
$16,006,037 |
+$5,492,842 |
2,611,099 |
+52% |
ARK Investment Management LLC |
31 Dec 2025 |
| THAR |
Tharimmune, Inc. |
Common Stock |
8.9% |
$9,853,660 |
|
3,252,033 |
|
ARK Investment Management LLC |
31 Dec 2025 |
| ABSI |
Absci Corp |
Common Stock |
8.6% |
$33,193,920 |
+$8,148,137 |
10,955,089 |
+33% |
ARK Investment Management LLC |
31 Mar 2025 |
| PSNL |
Personalis, Inc. |
Common Stock |
8.1% |
$27,530,795 |
+$1,580,878 |
7,188,197 |
+6.1% |
ARK Investment Management LLC |
31 Mar 2025 |
| SRTA |
Strata Critical Medical, Inc. |
Common Stock |
7.5% |
$32,407,200 |
|
6,404,585 |
|
ARK Investment Management LLC |
30 Sep 2025 |
| RXRX |
Recursion Pharmaceuticals, Inc. |
Class A Common Stock |
7.2% |
$152,625,941 |
+$20,329,177 |
37,316,856 |
+15% |
ARK Investment Management LLC |
31 Dec 2025 |
| TEM |
Tempus AI, Inc. |
Common Stock |
5.4% |
$506,423,380 |
|
9,446,435 |
|
ARK Investment Management LLC |
28 Feb 2026 |
| MASS |
908 Devices Inc. |
Common Stock |
5.4% |
$17,115,043 |
-$7,312,787 |
1,953,772 |
-30% |
ARK Investment Management LLC |
30 Sep 2025 |
| ACHR |
Archer Aviation Inc. |
Class A Common Stock, par value $0.0001 |
5.4% |
$264,483,672 |
+$73,113,320 |
35,170,701 |
+38% |
ARK Investment Management LLC |
31 Dec 2025 |
| VCYT |
VERACYTE, INC. |
Common Stock |
4.9% |
$163,682,056 |
-$24,345,827 |
3,887,547 |
-13% |
ARK Investment Management LLC |
31 Dec 2025 |
| QSI |
Quantum-Si Inc |
Common Stock |
4.8% |
$11,792,099 |
-$1,365,288 |
7,809,337 |
-10% |
ARK Investment Management LLC |
31 May 2025 |
| RPTX |
Repare Therapeutics Inc. |
Common Shares, no par value |
4.7% |
$2,199,996 |
|
1,999,996 |
|
ARK Investment Management LLC |
31 Dec 2024 |
| BFLY |
Butterfly Network, Inc. |
Common Stock |
4.7% |
$21,170,009 |
|
8,676,233 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| ROKU |
ROKU, INC |
Class A Common Stock, $0.0001 par value per share |
4.5% |
$638,109,756 |
-$159,493,102 |
5,881,738 |
-20% |
ARK Investment Management LLC |
31 Dec 2025 |
| CDNA |
CareDx, Inc. |
Common Stock |
4.5% |
$43,676,965 |
-$10,506,299 |
2,409,099 |
-19% |
ARK Investment Management LLC |
31 Dec 2024 |
| PATH |
UiPath, Inc. |
Class A common stock, par value $0.00001 per share |
4.5% |
$247,626,660 |
|
20,949,802 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| IRDM |
Iridium Communications Inc. |
Common Stock |
3.9% |
$68,710,210 |
-$39,609,693 |
4,116,849 |
-37% |
ARK Investment Management LLC |
30 Nov 2025 |
| VUZI |
Vuzix Corp |
Common Stock |
3.8% |
$488 |
|
249 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| KIND |
Nextdoor Holdings, Inc. |
Class A common stock, $0.0001 par value per share |
3.7% |
$10,210,270 |
|
6,898,831 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| ADPT |
Adaptive Biotechnologies Corporation |
Common Stock |
2.9% |
$40,863,635 |
-$15,506,311 |
4,398,669 |
-28% |
ARK Investment Management LLC |
31 May 2025 |
| KDK |
Kodiak AI, Inc. |
Common Stock, par value $0.0001 per share |
1.2% |
$15,424,241 |
+$9,134,225 |
2,255,006 |
+145% |
ARK Investment Management LLC |
31 Oct 2025 |
| PD |
PagerDuty, Inc. |
Common Stock |
0.24% |
$1,706,965 |
-$67,323,334 |
218,282 |
-98% |
ARK Investment Management LLC |
28 Feb 2026 |
| MKFG |
Markforged Holding Corp |
Common Stock, $0.0001 par value per share |
0% |
$0.2 |
|
1 |
-100% |
ARK Investment Management LLC |
31 Dec 2024 |
| NRIX |
Nurix Therapeutics Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| TDOC |
Teladoc Health, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| ACCD |
Accolade, Inc. |
Common Stock |
0% |
$0 |
-$37,785,382 |
0 |
-100% |
ARK Investment Management LLC |
31 Mar 2025 |
| DNA |
Ginkgo Bioworks Holdings, Inc. |
Class A Common Stock, par value $0.0001 |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| VERV |
Verve Therapeutics, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| VLD |
Velo3D, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| TWOU |
2U, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| SLGC |
SomaLogic, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
30 Sep 2024 |
| NVTAQ |
Invitae Corp |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
30 Sep 2024 |